COVID-19 Trials in New York, United States
Conditions / COVID-19 / New York, United States
COVID-19 is a medical condition with active clinical research programs worldwide.
49 total trials for this combination
Showing top 10 of 49 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04885530 | ACTIV-6: COVID-19 Study of Repurposed Medications | COMPLETED | PHASE3 |
| NCT06042855 | ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) | COMPLETED | PHASE3 |
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | COMPLETED | PHASE2/PHASE3 |
| NCT04505774 | Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE | COMPLETED | PHASE4 |
| NCT04824443 | Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19 | COMPLETED | PHASE1 |
| NCT05119400 | COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes | TERMINATED | — |
| NCT04611802 | A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 | COMPLETED | PHASE3 |
| NCT04650087 | COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis | COMPLETED | PHASE3 |
| NCT05077969 | Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients | TERMINATED | PHASE2 |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | COMPLETED | PHASE3 |